The synthesis and psychoactive effects of 5-MeO-MiPT were first described by Repke with recommended  doses of 4-6 mg for oral consumption and higher doses of 12-20 mg for administration via smoking. The attachment of a 5-methoxy group to the tryptamine core has been found to increase potency and to decrease the effects on perceptual changes in vision. N-Substitutions have also been reported to have an influence on the in vivo potency of tryptamines. It has been demonstrated that 5-MeO-MiPT inhibits the re-uptake of 5-HT, dopamine and norepinephrine, a mechanism of action similar to that of 5-MeO-DiPT.
Furthermore, it was shown to have little dopamine, 5-HT and norepinephrine releasing activity.
In Switzerland 5-MeO-MiPT is listed in the “Federal Act on Narcotics and Psychotropic Substances”
index e, No. 85. Until now, however, it has not been listed in  Germany.

SKU: N/A Category:


5-meo-mipt (5-Methoxy-N-methyl-N-isopropyltryptamine)

5-Methoxy-N-methyl-N-isopropyltryptamine (5-meo-mipt)

The psychedelic and hallucinogenic drug 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT)
is chemically related to  natural occurring tryptamine 5-MeO-DMT.

Analogue to synthetic tryptamine.

Equally known as Foxy; Foxy methoxy or simply methoxy

5-MeO-DiPT was placed in Schedule I of the Controlled Substances Act in the United States in 2004.

Conversely, studies have suggest potent neurotoxic effects on the serotonergic neurons with consistent behavioral data.

Clinically, it has shown to promote emotional expression, a talkative uninhibited state, visual and auditory sensory distortion.


Additional information


10g, 50g, 100g, 500g, 1000g


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.